Gary Schaer to Aged
This is a "connection" page, showing publications Gary Schaer has written about Aged.
Connection Strength
0.330
-
Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA? catheter mapping. Cardiovasc Revasc Med. 2018 12; 19(8S):50-52.
Score: 0.056
-
Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction. Crit Pathw Cardiol. 2014 Jun; 13(2):62-5.
Score: 0.046
-
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.
Score: 0.022
-
Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis. Catheter Cardiovasc Interv. 2003 Jun; 59(2):176-83.
Score: 0.021
-
Predictors of late cardiac events following treatment with Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2003 Jan-Mar; 4(1):7-11.
Score: 0.021
-
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018 06 14; 39(23):2208-2216.
Score: 0.015
-
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
Score: 0.014
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
Score: 0.013
-
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
Score: 0.013
-
The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
Score: 0.013
-
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J. 2013 Jun; 165(6):854-861.e2.
Score: 0.011
-
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
Score: 0.010
-
Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
Score: 0.008
-
Myocardial infarction after taking zolmitriptan. Yale J Biol Med. 2005 May; 78(3):147-50.
Score: 0.006
-
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol. 2005 Feb; 18(1):27-31.
Score: 0.006
-
Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):109-12.
Score: 0.006
-
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
Score: 0.005
-
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol. 2003 Aug 15; 92(4):436-9.
Score: 0.005
-
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol. 2003 Aug 01; 92(3):312-4.
Score: 0.005
-
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
Score: 0.005
-
Clinical outcomes of patients treated with the cutting balloon and Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):12-5.
Score: 0.005
-
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000 Nov 18; 356(9243):1705-10.
Score: 0.004
-
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
Score: 0.004
-
Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998 Jul 01; 82(1):43-9.
Score: 0.004
-
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
Score: 0.003
-
Excimer laser ablation before autoperfusion balloon inflation: a novel therapeutic approach to high grade stenoses in vessels supplying substantial myocardium at risk. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):202-8.
Score: 0.003
-
Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction. Am J Cardiol. 1987 Jun 01; 59(15):1231-3.
Score: 0.002
-
The coronary circulation in human septic shock. Circulation. 1986 Apr; 73(4):637-44.
Score: 0.002
-
Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol. 1983 Apr; 1(4):1154-9.
Score: 0.001